Skip to search formSkip to main contentSkip to account menu

doxaminol

Known as: 2-Propanol, 1-((2-(6,11-dihydrodibenz(b,e)oxepin-11-yl)ethyl)methylamino)-3-phenoxy-, BM 10 188 
A synthetic partial beta-adrenergic agonist with sympathomimetic activity. Doxaminol may bind to and stimulate beta-1-adrenergic receptors located in… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
The pharmacokinetic behaviour of doxaminol (N-methyl-N-(2-hydroxy-3-phenoxy-propyl)-11-(2-amino-ethyl)-6, 11-dihydrodibenz[b,e… 
1990
1990
The biotransformation of the positive inotropic compound doxaminol (N-methyl-N-(2-hydroxy-3-phenoxy-propyl)-11-(2-amino-ethyl)-6… 
1990
1990
The biotransformation of the positively inotropically active compound N-methyl-N-(2-hydroxy-3-phenoxy-propyl)-11-(2-aminoethyl)-6… 
1985
1985
Treatment of gravid rats (days 6-15 of gestation) with the beta-sympathomimetic doxaminol resulted in wavy ribs and bent limbs in… 
1985
1985
The interaction between digoxin and the beta-sympathomimetic drug doxaminol was investigated in cats with acute heart failure… 
1984
1984
SummaryThe enhanced arrhythmogenic risk of combined treatment with cardiac glycosides and beta-sympathomimetics is referred in… 
1983
1983
The hemodynamic effects of doxaminol, a new, orally applicable beta-agonist, chemically dissimilar to catecholamines, were… 
1982
1982
1 BM 10.188 (Doxaminol, Boehringer Mannheim, GmbH) is a recently developed beta-sympathomimetic agent which has shown promising…